LOCALIZED PANCREATIC ADENOCARCINOMA
Clinical trials for LOCALIZED PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALIZED PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALIZED PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple punch against pancreatic cancer: chemo, immunotherapy, and radiation before surgery
Disease control Recruiting nowThis study is testing a new approach for people with pancreatic cancer that can be surgically removed. Before surgery, patients receive a combination of chemotherapy (mFOLFIRINOX), an immunotherapy drug (pembrolizumab), and targeted radiation (SABR). After surgery, they continue …
Matched conditions: LOCALIZED PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New scan could spot pancreatic cancer more clearly
Diagnosis Recruiting nowThis study tests a special PET scan that uses a radioactive tracer called 68Ga-FAPI-46 to highlight pancreatic cancer cells. The goal is to see if this scan can find tumors more accurately than current methods. About 130 adults with early-stage pancreatic cancer will get the scan…
Matched conditions: LOCALIZED PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC